Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome von Davies, Robert W., Fiksinski, Ania M., Breetvelt, Elemi J., Williams, Nigel M., Hooper, Stephen R., Monfeuga, Thomas, Bassett, Anne S., Owen, Michael J., Gur, Raquel E., Morrow, Bernice E., McDonald-McGinn, Donna M., Swillen, Ann, Chow, Eva W. C., van den Bree, Marianne, Emanuel, Beverly S., Vermeesch, Joris R., van Amelsvoort, Therese, Arango, Celso, Armando, Marco, Campbell, Linda E., Cubells, Joseph F., Eliez, Stephan, Garcia-Minaur, Sixto, Gothelf, Doron, Kates, Wendy R., Murphy, Kieran C., Murphy, Clodagh M., Murphy, Declan G., Philip, Nicole, Repetto, Gabriela M., Shashi, Vandana, Simon, Tony J., Suñer, Damiàn Heine, Vicari, Stefano, Scherer, Stephen W., Bearden, Carrie E., Vorstman, Jacob A. S.

Volltext

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab von Berman, Horacio, Rodríguez-Pintó, Ignasi, Cervera, Ricard, Morel, Nathalie, Costedoat-Chalumeau, Nathalie, Erkan, Doruk, Shoenfeld, Yehuda, Espinosa, Gerard

Volltext

In vivo modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer von ROBINSON, E, RUBIN, D, MEKORI, T, SEGAL, R, POLLACK, S

Volltext

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the “CAPS Registry” von Cervera, Ricard, Bucciarelli, Silvia, Plasín, Miguel A, Gómez-Puerta, José A, Plaza, Joan, Pons-Estel, Guillermo, Shoenfeld, Yehuda, Ingelmo, Miguel, Espinos, Gerard, for the Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies)

Volltext

Pediatric catastrophic antiphospholipid syndrome: Descriptive analysis of 45 patients from the “CAPS Registry” von Berman, Horacio, Rodríguez-Pintó, Ignasi, Cervera, Ricard, Gregory, Simone, de Meis, Ernesto, Rodrigues, Carlos Ewerton Maia, Aikawa, Nádia Emi, de Carvalho, Jozélio Freire, Springer, Janusz, Niedzwiecki, Maciej, Espinosa, Gerard

Volltext

A novel 21‐kDa protein as a serum marker for benign and malignant urogenital tumors: Preliminary communication von Shalitin, C., Epelbaum, R., Valansi, C., Segal, R., Mekori, T., Lover, B., Robinson, E.

Volltext

Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’ von Cervera, R.

Volltext

Relapsing Catastrophic Antiphospholipid Syndrome Potential Role of Microangiopathic Hemolytic Anemia in Disease Relapses von Espinosa, Gerard, MD, PhD, Rodríguez-Pintó, Ignasi, MD, Gomez-Puerta, José A., MD, Pons-Estel, Guillermo, MD, PhD, Cervera, Ricard, MD, PhD, FRCP

Volltext

Lymphocyte subpopulations in patients with multiple primary tumors von ROBINSON, E, SEGAL, R, STRUMINGER, L, FARAGGI, D, EL'AD-YARUM, R, MEKORI, T

Volltext

Further observations on the effect of PHA in conjunction with radiotherapy and chemotherapy on S-180 in Swiss mice von Mekori, T., Robinson, E.

Volltext

Suppression of the Mitogenic Response to Phytohemagglutinin in Malignant Neoplasia: Correlation With Clinical Stage and Therapy von Mekori, Tamar, Sher, Shulamith, Robinson, Eliezer

Volltext

Combinations of the effect of radiotherapy, alkylating agents and phytohemagglutinin on Sarcoma 180 in Swiss mice von Robinson, E., Mekori, T.

Volltext

Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG) von Robinson, E, Bartal, A, Cohen, Y, Haim, N, Mohilever, J, Mekori, T

Volltext

Antibody production by 'cloned' cell populations von Feldman, M, Mekori, T

Volltext

Lymphocyte stimulation by phytohemagglutinin and tumor cells of malignant effusions von Robinson, E, Sher, S, Mekori, T

Volltext

Lymphocyte subpopulations in patients with multiple primary tumors von Robinson, E., Segal, R., Struminger, L., Faraggi, D., El'ad-Yarum, R., Mekori, T.

Volltext

Production of Clones of Lymphoid Cell Populations von MEKORI, T, CHIECO-BIANCI, L, FELDMAN, M

Volltext

Lymphocyte subpopulations in peripheral blood and malignant effusions of cancer patients von Robinson, E., Segal, R., Vesely, Z., Mekori, T.

Volltext

Interleukin-2 (IL-2). Interferon-α (IFN-α), 5-fluorouracil (5-FU) and vinblastine (VBL) for metastatic renal cell carcinoma (MRCC): A clinical and immunological study von Gez, E., Rubinov, R., Mekori, T., Struminger, L., Skigin, R., Keren, S., Haim, N., Kuten, A.

Volltext

Oral administration of the methanol extraction residue of BCG (MER/BCG): A phase I study in non-oat cell lung cancer patients von Bartal, A.H., Mordohovich, D., Lichtig, C., Mekori, T., Robinson, E.

Volltext